Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies

tildrakizumab治疗斑块状银屑病的疗效和安全性：持续给药、治疗中断、剂量调整以及从依那西普转换治疗的III期研究结果